DE
AZN icon

Diversified Enterprises’s AstraZeneca AZN Stock Holding History

Diversified Enterprises’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$882K Sell
4,654
-227
-5% -$42.7K 0.04% 177
2026
Q1 		$963K Buy
4,881
+371
+8% +$71.5K 0.05% 162
2025
Q4 		$829K Buy
4,510
+1,008
+29% +$177K 0.05% 154
2025
Q3 		$537K Buy
3,502
+20
+0.6% +$3.03K 0.04% 157
2025
Q2 		$487K Sell
3,482
-273
-7% -$38.3K 0.04% 164
2025
Q1 		$552K Buy
3,755
+1,654
+79% +$239K 0.05% 152
2024
Q4 		$275K Sell
2,101
-24
-1% -$3.36K 0.03% 200
2024
Q3 		$331K Buy
+2,125
New +$343K 0.04% 164

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Diversified Enterprises's AZN Position: Q2 2026 in Review

Diversified Enterprises reduced its AstraZeneca (AZN) stake by 4.7% in Q2 2026, selling an estimated $42.7K and leaving 4,654 shares worth $882K. The position accounts for 0.04% of the portfolio, ranked #177.

Diversified Enterprises first reported a position in AZN in Q3 2024 and has held it in 8 quarters since. The position peaked at $963K in Q1 2026. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Diversified Enterprises held 4,654 shares of AstraZeneca worth $882K as of Q2 2026.
  • Diversified Enterprises sold 227 AstraZeneca shares in Q2 2026, an estimated $42.7K.
  • AstraZeneca made up 0.04% of Diversified Enterprises's portfolio in Q2 2026, its #177 holding.
  • Diversified Enterprises first reported a position in AstraZeneca in Q3 2024 and has held it in 8 quarters since.
  • Diversified Enterprises's AstraZeneca position peaked at $963K in Q1 2026.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.